Zelira Therapeutics Ltd ZLD
Trading Information
- Previous Close Price
- A$0.50
- Day Range
- A$0.49–0.50
- 52-Week Range
- A$0.31–1.15
- Bid/Ask
- A$0.00 / A$0.00
- Shares Outstanding
- 13.15M
- Market Cap
- A$5.95M
- Volume/Avg
- 19,140 / 46,658
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8,771.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. The company is organised into two operating segments based on geographic location of operations: Australia and United States of America.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 8
- Website
- https://www.zeliratx.com
Valuation
|
Metric
|
ZLD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 8,771.93 |
Price/Cash Flow | — |
Price/Earnings
ZLD
Financial Strength
|
Metric
|
ZLD
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
ZLD
Profitability
|
Metric
|
ZLD
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ZLD
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|QbWVxy | LOCK|>^%K | $129B | |||
| Moderna Inc
MRNA
| LOCK|gVQ%#! | LOCK|y?q | $85B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|?G?z?C | LOCK|!HPG | $79B | |||
| argenx SE ADR
ARGX
| LOCK|!yM>cY | LOCK|DF! | $52B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|C%^Pp> | LOCK|MQ% | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|ktbP#K | LOCK|jjmZw | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^!c%Mdl | LOCK|RGF!c | $26B | |||
| BioNTech SE ADR
BNTX
| LOCK|QB^rHYW | LOCK|z<F | $24B | |||
| Incyte Corp
INCY
| LOCK|<XKQr>z | LOCK|c! | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|<Sh@kl< | LOCK|!B | $14B |
United States